Principia biopharma inc. (PRNB)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16
Revenue

35,160

69,137

5,247

0

Operating expenses:
Research and development

74,083

40,533

25,390

22,290

General and administrative

19,842

11,462

6,443

4,763

Total operating expenses

93,925

51,995

31,833

27,053

Loss from operations

-58,765

17,142

-26,586

-27,053

Other income, net

0

-653

5,096

308

Interest income

4,973

1,678

16

5

Interest expense

0

0

7,223

3,898

Net loss

-53,792

18,167

-28,697

-30,638

Net income (loss) attributable to common stockholders

-53,792

4,917

-28,697

-30,638

Net income (loss) per share attributable to common stockholders
Basic

-2.09

0.65

-50.37

-59.89

Diluted

-2.09

0.57

-50.37

-59.89

Weighted-average shares used to calculate net income (loss) per share attributable to common stockholders
Basic

25,778

7,622

569

511

Diluted

25,778

8,627

569

511